Mayo Clinic Tapestry 2.0: Applying Multi-Omics on Tapestry Participants for Scientific Discovery

Overview

About this study

The goals of this study are to collect and store biospecimens (e.g., blood, urine, saliva, stool) in order to support future research. These biospecimens will be tested and used to better understand why a disease or disorder occurs and how it progresses over time. This knowledge could aid future patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria :

Prior to Sample Collection:

  • Age ≥ 18 years
  • Registered Mayo Clinic patient
  • Able to provide informed written consent
  • Able to receive mail and packages within a US state
  • Able to collect and ship samples within a US state via FedEx

After Sample Collection:

  • Age ≥ 18 years
  • Registered Mayo Clinic patient

Exclusion Criteria:

Prior to Sample Collection:

  • Active hematological cancer or history of a hematological cancer
  • Allogeneic Bone Marrow Transplant (e.g., samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
  • Other co-morbidity that, in physician’s opinion, would interfere with patient’s ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)

After Sample Collection:

  • Co-morbidity that, in physician’s opinion, would interfere with patient’s ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/21/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Lazaridis, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Blake Clermont

(507) 538-7995

Clermont.Blake@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Richard Presutti, D.O.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Blake Clermont

(507) 538-7995

Clermont.Blake@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Niloy Jewel Samadder, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Blake Clermont

(507) 538-7995

Clermont.Blake@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20557491

Mayo Clinic Footer